Replies to post #233515 on Amarin Corp Plc (AMRN)

[stoneroad]

Agreed.

[bubbarayjr]

Remember AMRN is very conservative..this is a very low bar

[Jeffkad]

Yeah, seems low, but maybe trying to take into account slow formulary updates throughout the year. Unfortunately the delay from Sept to Dec f**ked AMRN as 2020 formulary decisions have prolly already been made. From some research I did, seems like most insurers/PBMs revise formularies within 3-6 months of new drug approvals, or at least that’s their stated goals.

[IgnoranceIsBliss]

dmiller, JT has been a consistent underpromise overdeliver guy

I think they can do a billion, but a double would still be great

Doubling every year for 3 years gets us to $3.2bn in 2022 -- which is pretty realistic with Europe and more ROW coming online

And additional indications possibly

[Mellowmood77]

There is underpromise, and then there is this. With Sam’s script numbers TODAY we are on track for 550 million in revenue.